Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 14, 2005 16:11 ET | Source: Actavis

Actavis Reports Record Profits and EBITDA Margins in Third Quarter

REYKJAVIK, Iceland, Nov. 14, 2005 (PRIMEZONE) -- Actavis Group (ICEX:ACT), the international generic pharmaceuticals company, today announces its results for the third quarter ended 30 September...
October 11, 2005 05:44 ET | Source: Actavis

Svafa Gronfeldt Appointed Deputy to the CEO of Actavis Group

REYKJAVIK, Iceland, Oct. 11, 2005 (PRIMEZONE) -- Svafa Gronfeldt has been appointed Deputy to the CEO of Actavis Group. Svafa joined Actavis in 2004 as Chief Executive of Strategy and Organisational...
September 30, 2005 06:19 ET | Source: Actavis

Actavis Acquires Keri Pharma Generics as Part of its Expansion Strategy in the CEE region

REYKJAVIK, Iceland, Sept. 30, 2005 (PRIMEZONE) -- Actavis Group (ICEX:ACT), the international generic pharmaceutical company, today announces that it has acquired the generic business of the...
September 05, 2005 07:45 ET | Source: Actavis

Actavis' Subsidiary Amide Receives FDA approval for Mirtazapine ODT

REYKJAVIK, Iceland, Sept. 5, 2005 (PRIMEZONE) -- Actavis Group hf.("ACT") today announces that Amide Pharmaceutical Inc., a subsidiary of Actavis Group in New Jersey USA, has received approval from...
August 30, 2005 09:34 ET | Source: Actavis

The Actavis Group: Organisational Changes in Sales & Marketing International

REYKJAVIK, Iceland, Aug. 30, 2005 (PRIMEZONE) -- The Actavis Group today announces that it has made organizational changes within its Sales and Marketing International division (Own-label sales) and...
August 10, 2005 10:08 ET | Source: Actavis

Mark Keatley Appointed as Actavis Group's Chief Executive of Finance

REYKJAVIK, Iceland, Aug. 10, 2005 (PRIMEZONE) -- Actavis Group hf. ("ACT") announces today that Mark Keatley has been appointed as Chief Executive of Finance of the Actavis Group from 1 September and...
August 09, 2005 15:46 ET | Source: Actavis

Actavis Reports Net Profits of EUR 22.4 Million for 1H 2005

HAFNARFIRDHI, Iceland, Aug. 9, 2005 (PRIMEZONE) -- Actavis Group hf. ("ACT"), the international generic pharmaceuticals company, announces its results for the quarter ended 30 June 2005. Highlights...